Correlation Analysis of the Therapy Adherence to Long-Acting Inhalers Among Patients with Stable COPD

References

• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):ITC17–ITC32. doi:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Stolz D. Chronic obstructive pulmonary disease risk: does genetics hold the answer? Lancet Respir Med. 2020;8(7):653–654. doi:10.1016/S2213-2600(20)30191-0
   PubMed Web of Science ®Google Scholar
• Dai J, Yang P, Cox A, Jiang G. Lung cancer and chronic obstructive pulmonary disease: from a clinical perspective. Oncotarget. 2017;8(11):18513–18524. doi:10.18632/oncotarget.14505
   PubMedGoogle Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• GOLD. From the Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://goldcopd.org. Accessed June 12, 2023.
   Google Scholar
• Wiśniewski D, Porzezińska M, Gruchała-Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104. doi:10.5603/PiAP.2014.0015
   PubMedGoogle Scholar
• Van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res. 2014;15(1):66. doi:10.1186/1465-9921-15-66
   PubMed Web of Science ®Google Scholar
• Kim JA, Lim MK, Kim K, Park J, Rhee CK. Adherence to inhaled medications and its effect on healthcare utilization and costs among high-grade chronic obstructive pulmonary disease patients. Clin Drug Investig. 2018;38(4):333–340. doi:10.1007/s40261-017-0612-2
   PubMed Web of Science ®Google Scholar
• Koehorst-Ter Huurne K, Kort S, van der Palen J, et al. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related. Int J Chron Obstruct Pulmon Dis. 2016;11:1679–1688. doi:10.2147/COPD.S107303
   PubMed Web of Science ®Google Scholar
• Jang JG, Lee KH, Chung JH, et al. Assessment of inhaler satisfaction and determinants of high satisfaction among Korean COPD patients. J Korean Med Sci. 2022;37(46):e327. doi:10.3346/jkms.2022.37.e327
   PubMed Web of Science ®Google Scholar
• Tangirala NC, O’Conor R, Wolf MS, Wisnivesky JP, Federman AD. Validity of the medication adherence rating scale for adherence to inhaled corticosteroids among older adults with asthma or chronic obstructive pulmonary disease. COPD. 2020;17(1):74–80. doi:10.1080/15412555.2020.1712688
   PubMedGoogle Scholar
• Cohen JL, Mann DM, Wisnivesky JP, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma. Ann Allergy Asthma Immunol. 2009;103(4):325–331. doi:10.1016/s1081-1206(10)60532-7
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Fabbri LM. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res. 2010;11(1):149. doi:10.1186/1465-9921-11-149
   PubMedGoogle Scholar
• Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012;9(3):251–258. doi:10.3109/15412555.2011.650241
   PubMedGoogle Scholar
• Koehorst-Ter Huurne K, Groothuis-Oudshoorn CG, vanderValk PD, Movig KL, van der Palen J, Brusse-Keizer M. Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1683–1690. doi:10.2147/COPD.S161374
   PubMed Web of Science ®Google Scholar
• Sorino C, Negri S, Spanevello A, Visca D, Scichilone N. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler. Eur J Intern Med. 2020;75(75):15–18. doi:10.1016/j.ejim.2020.02.023
   PubMedGoogle Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-3
   PubMed Web of Science ®Google Scholar
• Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui YM. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis. J Clin Pharm Ther. 2020;45(5):904–917. doi:10.1111/jcpt.13126
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action; 2003. Available from: http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf. Accessed July 31, 2017.
   Google Scholar
• Albassam A, Alharbi A, Awaisu A. Assessing adherence to inhaled corticosteroids among adults with asthma in Kuwait using the medication adherence report scale for asthma. Patient Prefer Adherence. 2020;14:963–970. doi:10.2147/PPA.S248655
   PubMed Web of Science ®Google Scholar
• Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):S25–S37. doi:10.1089/jamp.2010.0853
   PubMedGoogle Scholar
• Mahler DA. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease. Respir Med. 2020;161:105857. doi:10.1016/j.rmed.2019.105857
   PubMed Web of Science ®Google Scholar
• Anzueto A, Wise R, Calverley P, et al. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) trial: spirometry outcomes. Respir Res. 2015;16(1):107. doi:10.1186/s12931-015-0269-4
   PubMedGoogle Scholar
• Brand P, Hederer B, Austen G, Dewberry H, Meyer T. Higher lung deposition with respimat soft mist inhaler than HFA-MDI in COPD patients with poor technique. Int J Chron Obstruct Pulmon Dis. 2008;3(4):763–770. doi:10.2147/COPD.S3930
   PubMedGoogle Scholar
• Wittbrodt ET, Millette LA, Evans KA, Bonafede M, Tkacz J, Ferguson GT. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers. Int J Chron Obstruct Pulmon Dis. 2018;14:101–114. doi:10.2147/COPD.S177213
   PubMed Web of Science ®Google Scholar
• González-Torralba F, Baloira A, Abad A, et al. FIDEPOC: consensus on inspiratory flow and lung deposition as key decision factors in COPD inhaled therapy. Int J Chron Obstruct Pulmon Dis. 2022;17:1005–1015. doi:10.2147/COPD.S360938
   PubMed Web of Science ®Google Scholar
• Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120(5):1153–1159. doi:10.1016/j.jaci.2007.08.020
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Self regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32. doi:10.1080/08870440290001502
   Web of Science ®Google Scholar
• Laforest L, El Hasnaoui A, Pribil C, et al. Asthma patients’ self-reported behaviours toward inhaled corticosteroids. Respir Med. 2009;103(9):1366–1375. doi:10.1016/j.rmed.2009.03.010
   PubMed Web of Science ®Google Scholar
• Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64(1):41–46. doi:10.1016/j.jpsychores.2007.05.004
   PubMed Web of Science ®Google Scholar
• Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Int J Chron Obstruct Pulmon Dis. 2018;13:695–702. doi:10.2147/COPD.S149404
   PubMed Web of Science ®Google Scholar
• Jang JG, Kim JS, Chung JH, et al. Comprehensive effects of organized education for patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2603–2609. doi:10.2147/COPD.S221673
   PubMed Web of Science ®Google Scholar
• Hall RL, Willgoss T, Humphrey LJ, Kongsø JH. The effect of medical device dose-memory functions on patients’ adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence. 2014;8:775–788. doi:10.2147/PPA.S61248
   PubMed Web of Science ®Google Scholar
• Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol. 2007;119(4):811–816. doi:10.1016/j.jaci.2006.11.700
   PubMed Web of Science ®Google Scholar
• Takaku Y, Kurashima K, Ohta C, et al. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease? Respir Med. 2017;123:110–115. doi:10.1016/j.rmed.2016.12.012
   PubMed Web of Science ®Google Scholar